GILEAD SCIENCES, INC. (GILD)
Healthcare · Biological Products, (No Diagnostic Substances)
GILEAD SCIENCES, INC. (GILD) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.
Top institutional holders (2026-Q3)
| Institution | Shares | Value | % Outstanding |
|---|---|---|---|
| Robeco Institutional Asset Management B.V. | 3,442,819 | $513.15M | 0.28% |
| Sumitomo Mitsui Trust Group, Inc. | 2,972,668 | $443.08M | 0.24% |
| Swedbank AB | 2,875,154 | $428.54M | 0.23% |
| DekaBank Deutsche Girozentrale | 2,360,454 | $356.8K | 0.19% |
| Pictet Asset Management Holding SA | 2,348,141 | $351.41M | 0.19% |
| PRINCIPAL FINANCIAL GROUP INC | 1,965,786 | $293.00M | 0.16% |
| MACKENZIE FINANCIAL CORP | 1,951,700 | $290.90M | 0.16% |
| Assenagon Asset Management S.A. | 1,560,454 | $232.59M | 0.13% |
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-11-02 | O'Day Daniel Patrick | Chairman & CEO, Director | Sale | $267.8K |
| 2026-11-02 | O'Day Daniel Patrick | Chairman & CEO, Director | Sale | .33M |
| 2026-11-02 | O'Day Daniel Patrick | Chairman & CEO, Director | Sale | $342.1K |
| 2026-11-02 | O'Day Daniel Patrick | Chairman & CEO, Director | Sale | $322.3K |
| 2026-11-02 | O'Day Daniel Patrick | Chairman & CEO, Director | Sale | $285.8K |
| 2026-10-30 | O'Day Daniel Patrick | Chairman & CEO, Director | Sale | $2.78M |
| 2026-10-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | Sale | $468.7K |
| 2026-10-15 | Dickinson Andrew D | Chief Financial Officer | Sale | $468.7K |